Yoichi Sugiyama
Overview
Explore the profile of Yoichi Sugiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugiyama Y, Tahara N, Honda A, Koga Y, Yoshimura-Takubo H, Yoshimura H, et al.
Int J Cardiol
. 2025 Mar;
429:133126.
PMID: 40058610
Background: Invasive right heart catheterization plays a central role in identifying pulmonary hypertension (PH) disorders. However, non-invasive biomarkers of portopulmonary hypertension (PoPH) are required. Liver stiffness evaluated by FibroScan® is...
2.
Yamanaka F, Shishido K, Moriyama N, Ochiai T, Miyashita H, Yokoyama H, et al.
JACC Cardiovasc Interv
. 2025 Jan;
18(4):492-502.
PMID: 39797833
Background: Evidence regarding the incidence of prosthesis-patient mismatch (PPM) and long-term mortality after transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve stenosis (AS) is scarce. Objectives: This...
3.
Sugiyama Y, Miyashita H, Dahlbacka S, Vahasilta T, Vainikka T, Jalanko M, et al.
Cardiovasc Revasc Med
. 2024 Dec;
PMID: 39732605
Background/purpose: Transcatheter aortic valve replacement (TAVR) with ACURATE neo2 showed better hemodynamic outcomes by mitigating paravalvular leakage (PVL) compared with ACURATE neo, and revealed promising one-year outcomes in single-arm studies....
4.
Yamaji K, Sasaki K, Nakano M, Yoshiga T, Sasaki M, Sugiyama Y, et al.
PLoS One
. 2024 Oct;
19(10):e0312609.
PMID: 39446699
A device that can evaluate human pulmonary microcirculation is currently unavailable. This study aimed to establish a novel approach for assessing pulmonary microcirculation in patients with pulmonary hypertension (PH). We...
5.
Yokoyama H, Yamanaka F, Shishido K, Moriyama N, Ochiai T, Miyashita H, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Sep;
26(1):107-117.
PMID: 39255370
Aims: In patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS), data on the differences in subsequent cardiac structure and function among stratified groups with flow gradient...
6.
Riihiniemi M, Piuhola J, Niemela M, Sugiyama Y, Kiviniemi H, Biancari F, et al.
Am J Cardiol
. 2024 Sep;
230:82-85.
PMID: 39233063
No abstract available.
7.
Sugiyama Y, Miyashita H, Ochiai T, Shishido K, Jalanko M, Yamanaka F, et al.
Cardiovasc Revasc Med
. 2024 Jun;
PMID: 38944598
Background/purpose: Although the impact of predicted prosthesis-patient mismatch (PPM) on outcomes after surgical aortic valve replacement is well established, studies on PPM in transcatheter aortic valve replacement (TAVR) are limited....
8.
Morita K, Tahara N, Bekki M, Honda A, Tahara A, Maeda-Ogata S, et al.
J Nucl Cardiol
. 2024 Jun;
39:101887.
PMID: 38830569
No abstract available.
9.
Yamane H, Sugiyama Y, Komo T, Shibata K, Tazaki T, Koyama M, et al.
Case Rep Oncol
. 2024 Mar;
17(1):463-470.
PMID: 38464998
Introduction: Trastuzumab deruxtecan (T-Dxd) has been approved for the treatment of HER2-positive gastric cancer. However, there are only a limited number of cases of gastric cancer where a long-term complete...
10.
Sugiyama Y, Miyashita H, Yokoyama H, Ochiai T, Shishido K, Jalanko M, et al.
Am J Cardiol
. 2023 Dec;
213:151-160.
PMID: 38103766
Preexisting right bundle branch block (RBBB) is the strongest predictor for permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI). However, the risk assessment for new PPI and effective...